| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Interim Chief Executive
1 company
Albert Luderer is Interim Chief Executive at BNGO. Albert Luderer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10K at current prices.
Net of sales, the BNGO filings show accumulation of 8,000 shares.
Albert Luderer has 11 Form 4 filings on record from October 2018 to September 2026, all as Interim Chief Executive at Bionano Genomics (BNGO), 2018–2026.
The 11 reported transactions were 9 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $10K and no sales.
The largest open-market purchase was 4,000 shares of BNGO at an average $1.22 on August 21, 2026, about $5K.